Search

everythinglearnresearchcommunity

for

Search:↓

Special cells can help regrow hair in alopecia areata.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Finasteride may help treat BPH by affecting certain biological markers.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Both treatments help hair regrowth, but Botulinum Toxin-A has fewer side effects.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

TGF-alpha is present in sheep and ferret skin and may affect hair growth without directly stimulating cell proliferation.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Injection therapies show promise as effective treatments for hair loss.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.